Search

everythinglearnresearchcommunity

for

Search:↓

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

A woman's symptoms of increased body hair and testosterone were caused by a rare adrenal tumor, which was removed successfully.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Spironolactone may help reduce hair loss in androgenic alopecia.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.